Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Stomach Neoplasms 15Rectal Neoplasms 13Triple Negative Breast Neoplasms 10Pancreatic Neoplasms 7Neoplasm Metastasis 7Nasopharyngeal Carcinoma 6Colonic Neoplasms 6Neoplasms 4Gallbladder Neoplasms 4Cholangiocarcinoma 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Klatskin Tumor 2Esophageal Squamous Cell Carcinoma 2Colorectal Cancer Metastatic 2Clinical Stage I Gastric Cancer AJCC v8 2Biliary Tract Neoplasms 2Adenoma, Islet Cell 2Squamous Cell Carcinoma of Head and Neck 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1

Interventions

Temozolomide 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Islet Cell × Capecitabine × Clear all
NCT01824875 2026-02-25

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
144 enrolled 15 charts
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡